YCT-529, developed by US scientists, moves to early-stage phase 2 trial in New Zealand. Study published in Nature Communications showed it to be 99% effective in preclinical studies.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS